- Home
- LNKS vs BCLI Comparison
LNKS vs BCLI Comparison
Compare LNKS & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKS
- BCLI
- Stock Information
- Founded
- LNKS 1995
- BCLI 2000
- Country
- LNKS Malaysia
- BCLI United States
- Employees
- LNKS N/A
- BCLI N/A
- Industry
- LNKS
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LNKS
- BCLI Health Care
- Exchange
- LNKS NYSE
- BCLI Nasdaq
- Market Cap
- LNKS 8.7M
- BCLI 7.7M
- IPO Year
- LNKS 2024
- BCLI N/A
- Fundamental
- Price
- LNKS $0.60
- BCLI $1.22
- Analyst Decision
- LNKS
- BCLI Strong Buy
- Analyst Count
- LNKS 0
- BCLI 1
- Target Price
- LNKS N/A
- BCLI $30.00
- AVG Volume (30 Days)
- LNKS 239.8K
- BCLI 3.4M
- Earning Date
- LNKS 06-17-2025
- BCLI 05-15-2025
- Dividend Yield
- LNKS N/A
- BCLI N/A
- EPS Growth
- LNKS N/A
- BCLI N/A
- EPS
- LNKS N/A
- BCLI N/A
- Revenue
- LNKS $5,088,489.00
- BCLI N/A
- Revenue This Year
- LNKS N/A
- BCLI N/A
- Revenue Next Year
- LNKS N/A
- BCLI N/A
- P/E Ratio
- LNKS N/A
- BCLI N/A
- Revenue Growth
- LNKS N/A
- BCLI N/A
- 52 Week Low
- LNKS $0.45
- BCLI $0.72
- 52 Week High
- LNKS $10.27
- BCLI $8.09
- Technical
- Relative Strength Index (RSI)
- LNKS N/A
- BCLI 55.90
- Support Level
- LNKS N/A
- BCLI $1.05
- Resistance Level
- LNKS N/A
- BCLI $1.18
- Average True Range (ATR)
- LNKS 0.00
- BCLI 0.14
- MACD
- LNKS 0.00
- BCLI 0.00
- Stochastic Oscillator
- LNKS 0.00
- BCLI 23.91
About LNKS LINKERS INDUSTRIES LIMITED
Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.